Sunday, July 12, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 77 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 8143445

    HDAC inhibitors

    Lixte Biotechnology, Inc. · Granted Mar 27, 2012 · Expires Mar 22, 2032

    granted
  2. US 8143412

    Inhibitors of proliferation and activation of signal transducer and activator of transcription (STATs)

    The Board of Regents of the University of Texas System · Granted Mar 27, 2012 · Expires Mar 22, 2032

    granted
  3. US 8143252

    Tetrahalogenated compounds useful as inhibitors of angiogenesis

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Mar 27, 2012 · Expires Mar 22, 2032

    granted
  4. US 8133898

    Renin inhibitors

    Takeda Pharmaceutical Company Limited · Granted Mar 13, 2012 · Expires Mar 8, 2032

    granted
  5. US 8129381

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Mar 6, 2012 · Expires Mar 1, 2032

    granted
  6. US 8129399

    Aminopyrimidines useful as kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Mar 6, 2012 · Expires Mar 1, 2032

    granted
  7. US 8129387

    Substituted 5,6-dihydroimidazo[1,5-F]pteridines useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Mar 6, 2012 · Expires Mar 1, 2032

    granted
  8. US 8124766

    Inhibitors of diacylglycerol acyltransferase

    Madrigal Pharmaceuticals, Inc. · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted
  9. US 8124651

    Palmarumycin based inhibitors of thioredoxin and methods of using same

    THE ARIZONA BOARD OF REGENTS · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted
  10. US 8124584

    Macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted
  11. US 8119660

    Small-molecule inhibitors of the androgen receptor

    The Regents of the University of California · Granted Feb 21, 2012 · Expires Feb 16, 2032

    granted
  12. US 8119655

    Kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Feb 21, 2012 · Expires Feb 16, 2032

    granted
  13. US 8119656

    Inhibitors of the influenza virus non-structural 1 protein

    The Board of Regents of the University of Texas System · Granted Feb 21, 2012 · Expires Feb 16, 2032

    granted
  14. US 8119631

    Inhibitors of interleukin-1β converting enzyme

    Vertex Pharmaceuticals Incorporated · Granted Feb 21, 2012 · Expires Feb 16, 2032

    granted
  15. US 8119649

    Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemia

    The Board of Regents of the University of Texas System · Granted Feb 21, 2012 · Expires Feb 16, 2032

    granted
  16. US 8115011

    Diacylglycerol acyltransferase inhibitors

    Madrigal Pharmaceuticals, Inc. · Granted Feb 14, 2012 · Expires Feb 9, 2032

    granted
  17. US 8101770

    Pyridones useful as inhibitors of kinases

    Vertex Pharmaceuticals Incorporated · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  18. US 8101567

    Heteroaryl-containing tripeptide HCV serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  19. US 8097630

    Pinane-substituted pyrimidinediamine derivatives useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Jan 17, 2012 · Expires Jan 12, 2032

    granted
  20. US 8093291

    Methods of using and compositions comprising tryptophan hydroxylase inhibitors

    LEXICON PHARMACEUTICALS, INC. · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted
  21. US 8093392

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted
  22. US 8093236

    Weekly administration of dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted
  23. US 8093274

    Inhibitors of protein prenyltransferases

    The Regents of the University of California · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted
  24. US 8093382

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted